Alfonso Maresca

4.7k total citations
60 papers, 4.2k citations indexed

About

Alfonso Maresca is a scholar working on Molecular Biology, Organic Chemistry and Physical and Theoretical Chemistry. According to data from OpenAlex, Alfonso Maresca has authored 60 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 48 papers in Organic Chemistry and 18 papers in Physical and Theoretical Chemistry. Recurrent topics in Alfonso Maresca's work include Enzyme function and inhibition (57 papers), Synthesis and Catalytic Reactions (47 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (21 papers). Alfonso Maresca is often cited by papers focused on Enzyme function and inhibition (57 papers), Synthesis and Catalytic Reactions (47 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (21 papers). Alfonso Maresca collaborates with scholars based in Italy, United States and France. Alfonso Maresca's co-authors include Claudiu T. Supuran, Andrea Scozzafava, Fabrizio Carta, Daniela Vullo, Claudia Temperini, Sally‐Ann Poulsen, Robert McKenna, Jean‐Yves Winum, Mayank Aggarwal and Bernard Masereel and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Alfonso Maresca

60 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Maresca Italy 34 3.7k 3.1k 1.2k 1.1k 130 60 4.2k
Anna Di Fiore Italy 32 4.0k 1.1× 2.6k 0.8× 1.3k 1.1× 1.0k 1.0× 177 1.4× 64 4.5k
Claudia Temperini Italy 28 2.5k 0.7× 1.8k 0.6× 897 0.7× 821 0.8× 209 1.6× 39 2.9k
Silvia Bua Italy 33 2.4k 0.6× 2.2k 0.7× 846 0.7× 437 0.4× 138 1.1× 112 3.0k
Mariangela Ceruso Italy 35 1.8k 0.5× 1.7k 0.5× 693 0.6× 331 0.3× 117 0.9× 64 2.3k
Mikhail Krasavin Russia 30 1.6k 0.4× 3.7k 1.2× 414 0.3× 181 0.2× 167 1.3× 341 4.7k
Muhammet Tanç Italy 25 1.4k 0.4× 1.3k 0.4× 548 0.4× 287 0.3× 72 0.6× 48 1.7k
Adel S. El‐Azab Saudi Arabia 39 1.7k 0.5× 3.2k 1.0× 479 0.4× 121 0.1× 332 2.6× 133 3.8k
Lionel Pochet Belgium 25 874 0.2× 973 0.3× 374 0.3× 147 0.1× 103 0.8× 61 1.9k
Sahar M. Abou‐Seri Egypt 32 1.2k 0.3× 2.1k 0.7× 394 0.3× 105 0.1× 279 2.1× 69 2.6k
Justo Cobo Spain 29 664 0.2× 3.0k 0.9× 310 0.2× 130 0.1× 138 1.1× 362 3.4k

Countries citing papers authored by Alfonso Maresca

Since Specialization
Citations

This map shows the geographic impact of Alfonso Maresca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Maresca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Maresca more than expected).

Fields of papers citing papers by Alfonso Maresca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Maresca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Maresca. The network helps show where Alfonso Maresca may publish in the future.

Co-authorship network of co-authors of Alfonso Maresca

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Maresca. A scholar is included among the top collaborators of Alfonso Maresca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Maresca. Alfonso Maresca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maresca, Alfonso, et al.. (2012). Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 28(2). 397–401. 88 indexed citations
2.
Winum, Jean‐Yves, Alfonso Maresca, Fabrizio Carta, Andrea Scozzafava, & Claudiu T. Supuran. (2012). Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. Chemical Communications. 48(66). 8177–8177. 69 indexed citations
3.
Maresca, Alfonso, Andrea Scozzafava, Stephan Köhler, Jean‐Yves Winum, & Claudiu T. Supuran. (2012). Inhibition of beta-carbonic anhydrases from the bacterial pathogen Brucella suis with inorganic anions. Journal of Inorganic Biochemistry. 110. 36–39. 26 indexed citations
4.
Compain, Guillaume, Agnès Martin‐Mingot, Alfonso Maresca, Sébastien Thibaudeau, & Claudiu T. Supuran. (2012). Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: New selective tumor-associated carbonic anhydrase inhibitors. Bioorganic & Medicinal Chemistry. 21(6). 1555–1563. 39 indexed citations
5.
Maresca, Alfonso, Meltem Alper, Feray Köçkar, et al.. (2012). Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: Influences on the catalytic activity and affinity for inhibitors. Bioorganic & Medicinal Chemistry. 20(7). 2208–2213. 5 indexed citations
6.
7.
Monti, Simona Maria, Alfonso Maresca, Fabrizio Carta, et al.. (2011). Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorganic & Medicinal Chemistry Letters. 22(2). 859–862. 85 indexed citations
8.
Pala, Nicolino, Roberto Dallocchio, Alessandro Dessì, et al.. (2011). Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore. Bioorganic & Medicinal Chemistry Letters. 21(8). 2515–2520. 7 indexed citations
9.
Fiore, Anna Di, Alfonso Maresca, Vincenzo Alterio, Claudiu T. Supuran, & Giuseppina De Simone. (2011). Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II. Chemical Communications. 47(42). 11636–11636. 48 indexed citations
10.
Rami, Marouan, Alfonso Maresca, Jean‐Louis Montero, et al.. (2011). Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. Bioorganic & Medicinal Chemistry Letters. 21(10). 2975–2979. 14 indexed citations
11.
Williams, Michael L., et al.. (2011). Synthesis of glycoconjugate carbonic anhydrase inhibitors by ruthenium-catalysed azide-alkyne 1,3-dipolar cycloaddition. Bioorganic & Medicinal Chemistry Letters. 21(20). 6058–6061. 27 indexed citations
12.
Carta, Fabrizio, Alfonso Maresca, Andrea Scozzafava, & Claudiu T. Supuran. (2011). 5- and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 267–270. 61 indexed citations
13.
Maresca, Alfonso & Claudiu T. Supuran. (2010). Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. Bioorganic & Medicinal Chemistry Letters. 20(15). 4511–4514. 126 indexed citations
14.
Köçkar, Feray, Alfonso Maresca, Semra Işık, et al.. (2010). Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorganic & Medicinal Chemistry. 18(15). 5498–5503. 8 indexed citations
15.
Maresca, Alfonso, Andrea Scozzafava, & Claudiu T. Supuran. (2010). 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorganic & Medicinal Chemistry Letters. 20(24). 7255–7258. 148 indexed citations
16.
Maresca, Alfonso, Fabrizio Carta, Daniela Vullo, Andrea Scozzafava, & Claudiu T. Supuran. (2009). Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 β-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 19(17). 4929–4932. 27 indexed citations
17.
Carta, Fabrizio, Alfonso Maresca, Adrian Suárez Covarrubias, et al.. (2009). Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorganic & Medicinal Chemistry Letters. 19(23). 6649–6654. 97 indexed citations
18.
Carta, Fabrizio, et al.. (2009). Carbonic Anhydrase Inhibitors: Inhibition of Cytosolic Carbonic Anhydrase Isozymes II and VII with Simple Aromatic Sulfonamides and Some Azo Dyes. Chemical Biology & Drug Design. 74(2). 196–202. 16 indexed citations
19.
Carta, Fabrizio, Alfonso Maresca, Andrea Scozzafava, Daniela Vullo, & Claudiu T. Supuran. (2009). Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. Bioorganic & Medicinal Chemistry. 17(20). 7093–7099. 21 indexed citations
20.
Maresca, Alfonso & Claudiu T. Supuran. (2008). Muscarinic acetylcholine receptors as therapeutic targets for obesity. Expert Opinion on Therapeutic Targets. 12(9). 1167–1175. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026